Dr. Yungpo B Su, MD
Claim this profileHeartland Oncology and Hematology LLP
Studies Cancer
Studies Squamous Cell Carcinoma
8 reported clinical trials
12 drugs studied
Area of expertise
1Cancer
Stage IV
Stage III
Stage I
2Squamous Cell Carcinoma
Stage III
Stage IV
PD-L1 positive
Affiliated Hospitals
Clinical Trials Yungpo B Su, MD is currently running
Pembrolizumab + Radiation vs Chemotherapy + Radiation
for Head and Neck Cancer
This phase II trial studies the effect of pembrolizumab alone compared to the usual approach (chemotherapy \[cisplatin and carboplatin\] plus radiation therapy) after surgery in treating patients with head and neck squamous cell carcinoma that has come back (recurrent) or patients with a second head and neck cancer that is not from metastasis (primary). Radiation therapy uses high energy radiation or protons to kill tumor cells and shrink tumors. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of cancer cells. Carboplatin is also in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer and may interfere with the ability of tumor cells to grow and spread. Giving pembrolizumab alone after surgery may work better than the usual approach in shrinking recurrent or primary head and neck squamous cell carcinoma.
Recruiting1 award Phase 231 criteria
Radiation Therapy + Cisplatin
for Head and Neck Cancer
This trial is studying if using a specific type of energy treatment alone or with a drug is better for treating patients with advanced head and neck cancer after surgery. The energy treatment kills cancer cells, and the drug helps by stopping their growth or killing them. The drug has been used for many years in the treatment of advanced cancers, including head and neck cancers, and is known for its ability to enhance the effects of the energy treatment.
Recruiting1 award Phase 219 criteria
More about Yungpo B Su, MD
Clinical Trial Related3 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Yungpo B Su, MD has experience with
- Nivolumab
- Cisplatin
- Pembrolizumab
- Ipilimumab
- Seribantumab
- Intensity-Modulated Radiation Therapy
Breakdown of trials Yungpo B Su, MD has run
Cancer
Squamous Cell Carcinoma
Oropharyngeal Carcinoma
Laryngeal Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Yungpo B Su, MD specialize in?
Yungpo B Su, MD focuses on Cancer and Squamous Cell Carcinoma. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Yungpo B Su, MD currently recruiting for clinical trials?
Yes, Yungpo B Su, MD is currently recruiting for 4 clinical trials in Council Bluffs Iowa. If you're interested in participating, you should apply.
Are there any treatments that Yungpo B Su, MD has studied deeply?
Yes, Yungpo B Su, MD has studied treatments such as Nivolumab, Cisplatin, Pembrolizumab.
What is the best way to schedule an appointment with Yungpo B Su, MD?
Apply for one of the trials that Yungpo B Su, MD is conducting.
What is the office address of Yungpo B Su, MD?
The office of Yungpo B Su, MD is located at: Heartland Oncology and Hematology LLP, Council Bluffs, Iowa 51503 United States. This is the address for their practice at the Heartland Oncology and Hematology LLP.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.